Chinese pharmaceutical group floats on AIM

Pharmaceutical group China Medical System Holdings (CMSH) commenced trading on AIM this week. Its placing price was 138p and it is now trading around 146p.

The placing raised approximately £10 million for CMSH and the market capitalisation at the issue price was £65.2 million.

The company focuses on research and development (R&D), manufacturing, distribution and marketing of pharmaceuticals primarily within China, and bills itself as ‘a gateway to China for small and medium-sized foreign drug companies’.

It was established in 1995 and began its R&D operations six years ago. Since then it has obtained 37 patents within China, and two overseas. Its revenues have grown at a compound average rate of 20 per cent in the past three years.

Marc Barber

Marc Barber

Marc was editor of GrowthBusiness from 2006 to 2010. He specialised in writing about entrepreneurs, private equity and venture capital, mid-market M&A, small caps and high-growth businesses.

Related Topics

Pharmaceutical industry